P. Vreken
- Clinical Biochemistry top 0.2%
- Metabolism and Genetic Disorders 41
- Biochemistry top 1%
- Molecular Biology top 2%
- Biochemical and Molecular Research 28
- Peroxisome Proliferator-Activated Receptors 23
- Mitochondrial Function and Pathology 9
- RNA modifications and cancer 9
- Cancer therapeutics and mechanisms 7
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Physiology top 5%
-
- Neonatal Health and Biochemistry 11
- Co-authors
- Ronald J. A. WandersAndré B. P. KuilenburgHans R. WaterhamA. H. van GennipAlbert H. GennipP. G. BarthSacha FerdinandusseRonney A. De Abreu
- Journals
- Journal of Inherited Metabolic Disease (24 papers)Biochemical Society Transactions (6 papers)Advances in experimental medicine and biology (6 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
P. Vreken
81 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 1.2k
- Biochemistry 348
- Molecular Biology 3.3k
- Oncology 942
- Physiology 594
Countries citing papers authored by P. Vreken
This map shows the geographic impact of P. Vreken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vreken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vreken more than expected).
Fields of papers citing papers by P. Vreken
This network shows the impact of papers produced by P. Vreken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vreken. The network helps show where P. Vreken may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Vreken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 86 | |
| 2 | 2002 | 16 | |
| 3 | 2001 | 43 | |
| 4 | 2001 | 199 | |
| 5 | Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. | 2000 | 307 |
| 6 | 2000 | 3 | |
| 7 | 2000 | 24 | |
| 8 | 2000 | 25 | |
| 9 | 1999 | 5 | |
| 10 | 1999 | 30 | |
| 11 | Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G -> A point mutation (vol 21, pg 280, 1998) | 1998 | 1 |
| 12 | 1998 | 21 | |
| 13 | 1998 | 5 | |
| 14 | 1998 | 53 | |
| 15 | 1998 | 5 | |
| 16 | 1998 | 10 | |
| 17 | 1998 | 223 | |
| 18 | 1998 | 81 | |
| 19 | 1997 | 90 | |
| 20 | 1993 | 7 |
About P. Vreken
P. Vreken is a scholar working on Clinical Biochemistry, Biochemistry and Molecular Biology, having authored 81 papers that have together received 4.5k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (41 papers), Biochemical and Molecular Research (28 papers), Peroxisome Proliferator-Activated Receptors (23 papers), Neonatal Health and Biochemistry (11 papers), Mitochondrial Function and Pathology (9 papers), RNA modifications and cancer (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Clinical Biochemistry (1.2k citations), Biochemistry (348 citations) and Molecular Biology (3.3k citations). P. Vreken has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Ronald J. A. Wanders, André B. P. Kuilenburg, Hans R. Waterham, A. H. van Gennip, Albert H. Gennip, P. G. Barth, Sacha Ferdinandusse, Ronney A. De Abreu, Rutger Meinsma and E.G. van Grunsven. Their work appears in journals such as Journal of Inherited Metabolic Disease, Biochemical Society Transactions, Advances in experimental medicine and biology, The Journal of Pediatrics and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.